Luteijn, JMWhite, BCGunnlaugsdottir, HHolm, FKalogeras, NLeino, OMagnusson, SHOdekerken, GPohjola, MVTijhuis, MJTuomisto, JTUeland, OMcCarron, PAVerhagen, H2025-03-212025-03-2120122168311510.1016/j.fct.2011.06.008https://rivm.openrepository.com/handle/10029/646596State of the art in benefit-risk analysis: medicinesArticleFood Chem Toxicol 2012; 50(1):26-322025-03-21